U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06930729) titled 'Optimizing Care for Cancer Survivors With Depression: Project 3' on April 09.
Brief Summary: The purpose of this research study is to evaluate different depression treatment approaches among cancer survivors. A cancer survivor is defined as anyone who is living and has been diagnosed with cancer.
Participants will be randomly assigned to either receive a mobile app for depression treatment, called "Moodivate", or to receive telehealth depression treatment sessions. Approximately 2/3 of participants enrolled will receive the mobile app and the remaining 1/3 will receive depression treatment via telehealth. Participants that receive...